News
Hosted on MSN2h
WeightWatchers shuns compounded semaglutide amid FDA rulesThe company pursued this strategy amid waning interest in diet and lifestyle changes, with people preferring to take weight ...
Personal wellness company WeightWatchers (NASDAQ:WW) reported Q2 CY2025 results topping the market’s revenue expectations, ...
WW International (WW) shares higher with Q2 results post-bankruptcy, boosted by Clinical unit growth. Discover revenue ...
Successful completion of strategic reorganization, reducing debt by $1.15 billion.In connection with emergence on 6/24/25, fiscal Q2 consists of a "Predecessor" period from 3/30/25 to 6/24/25, and a ...
Successful completion of strategic reorganization, reducing debt by $1.15 billion.In connection with emergence on 6/24/25, fiscal Q2 consists of a "Predecessor" period from 3/30/25 to 6/24/25, and a ...
Novo Nordisk (NVO) said Wednesday it will cut costs as it faces increasing competition from Eli Lilly (LLY) and generic versions of its obesity drug Wegovy, with slower growth expected for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback